Arbutus Biopharma Corp — Institutional Ownership
Which tracked institutions hold ABUS, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
25
Funds holding
$275903188
Total value held
Buying
19 added/new · 6 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Morgan Stanley | $84951868 | 17698305 | -8193175 | -31.64% |
| 2 | Blackrock, Inc. | $66077140 | 13766071 | +799125 | +6.16% |
| 3 | State Street Corp | $37772059 | 7869179 | +1526669 | +24.07% |
| 4 | Barclays Plc | $20197987 | 4207914 | -108181 | -2.51% |
| 5 | Goldman Sachs Group Inc | $16832650 | 3506802 | +2406368 | +218.67% |
| 6 | Bank Of America Corp /De/ | $12701745 | 2646197 | +962569 | +57.17% |
| 7 | Jefferies Financial Group Inc. | $8216026 | 1711672 | +1711672 | NEW BUY |
| 8 | Nomura Holdings Inc | $7857989 | 1637081 | +1637081 | NEW BUY |
| 9 | Northern Trust Corp | $6811315 | 1419024 | +141165 | +11.05% |
| 10 | Citigroup Inc | $4220338 | 879237 | -691112 | -44.01% |
| 11 | Bank Of Montreal /Can/ | $3734102 | 777938 | -4825 | -0.62% |
| 12 | Bank Of New York Mellon Corp | $2179752 | 454115 | +74742 | +19.70% |
| 13 | Invesco Ltd. | $1204353 | 250907 | +250907 | NEW BUY |
| 14 | Ubs Group Ag | $1196198 | 249208 | +249208 | NEW BUY |
| 15 | Wells Fargo & Company/Mn | $710372 | 147994 | +89285 | +152.08% |
| 16 | Jpmorgan Chase & Co | $459688 | 98224 | +11175 | +12.84% |
| 17 | Janus Henderson Group Plc | $273746 | 60900 | +60900 | NEW BUY |
| 18 | Allstate Corp | $212285 | 44226 | +44226 | NEW BUY |
| 19 | Prudential Financial Inc | $126624 | 26380 | +3070 | +13.17% |
| 20 | Principal Financial Group Inc | $59030 | 12298 | +1321 | +12.03% |
| 21 | Ameriprise Financial Inc | $50241 | 10467 | +10467 | NEW BUY |
| 22 | Royal Bank Of Canada | $23000 | 4890 | +4781 | +4386.24% |
| 23 | Federated Hermes, Inc. | $19397 | 4041 | +4041 | NEW BUY |
| 24 | Pnc Financial Services Group, Inc. | $8112 | 1690 | -179 | -9.58% |
| 25 | Us Bancorp \De\ | $7171 | 1494 | -94 | -5.92% |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.